Related Experiment Videos
Cytokines and liver diseases
1Department of Medicine, University Hospital Innsbruck, Innsbruck, Austria. Herbert.Tilg@uibk.ac.at
Summary
Cytokines, like tumor necrosis factor-alpha (TNF-a), drive liver inflammation and injury but are also crucial for liver regeneration. Targeting these cytokines for liver disease treatment presents a complex challenge for future clinical trials.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Cytokines are peptides produced by nucleated cells, with minimal constitutive production in tissues like the liver.
- Cytokines are increasingly recognized for their dual role in mediating liver injury (inflammation, apoptosis, necrosis, fibrosis, cholestasis) and regeneration.
Purpose of the Study:
- To review the multifaceted roles of cytokines, particularly tumor necrosis factor-alpha (TNF-a), in liver disease pathogenesis and regeneration.
- To highlight the therapeutic potential and challenges of targeting cytokines in liver disease treatment.
Main Methods:
- Literature review and synthesis of existing evidence on cytokine involvement in liver pathophysiology.
- Focus on tumor necrosis factor-alpha (TNF-a) as a key mediator in liver disease.
Main Results:
- Cytokines, including TNF-a, are implicated in hepatic inflammation, cell death, cholestasis, and fibrosis.
- The same cytokines that cause injury are essential for liver tissue regeneration following damage.
Conclusions:
- Antagonism of TNF-a and other cytokines is a potential therapeutic strategy for liver diseases.
- Inhibiting these cytokines may impede crucial liver regeneration processes, posing a clinical challenge for future anticytokine therapies.